Back to Journals » Vascular Health and Risk Management » Volume 19

The Benefits of Polypill: Adherence and Chronotherapy [Response to Letter]

Authors Lopez-Jaramillo P , Lopez-Lopez JP 

Received 22 September 2023

Accepted for publication 2 October 2023

Published 13 October 2023 Volume 2023:19 Pages 661—662

DOI https://doi.org/10.2147/VHRM.S441580



Patricio Lopez-Jaramillo, Jose P Lopez-Lopez

Masira Research Institute, Medical School, Universidad de Santander, Bucaramanga, Colombia

Correspondence: Patricio Lopez-Jaramillo, Email [email protected]


View the original paper by Dr Lopez-Lopez and colleagues

This is in response to the Letter to the Editor


Dear editor

We would like to acknowledge the interest of Zhu and Zhou1 in our article2 showing the beneficial effect of polypill on medical adherence and on the improvement of cardiovascular outcomes. In his letter, the above authors discuss the eventual role of the time of the oral administration of polypill, suggesting that bedtime could be more appropriate as demonstrated by the only work that has investigated the circadian effect of polypill administration.3 In our metaanalysis, except for the refereed article of Lafeber et al,3 most of the other articles reported that the polypill was administered once a day with the timing suggested by the physician and others not reported the time of administration. We agree that circadian rhythms are crucial for maintaining vascular function and that disruption of these rhythms are associated with cardiovascular disease, atherosclerosis, and hypertension.4,5 Moreover, as cited by the Zhu and Zhou exit evidence about the optimal time to administer once-daily oral cardiovascular drugs. However, in our view, we will need more studies confirming the advantage of administering the polypill it in the evening or at bedtime. By now the important news is that polypill has been included in the World Health Organization Model List of Essential Medicines.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Ling-Ling Z, Zhou Q. Polypill brings benefits to patients with cardiovascular disease, both improving medication adherence and demonstrating the concept of chronotherapy [Letter]. Vasc Health Risk Manag. 2023;19:659–660. doi:10.2147/VHRM.S440353

2. Lopez-Lopez JP, Gonzalez AM, Lanza P, Lopez-Jaramillo P. Benefits of the polypill on medication adherence in the primary and secondary prevention of cardiovascular disease: a systematic review. Vasc Health Risk Manag. 2023;19:605–615. doi:10.2147/VHRM.S421024

3. Lafeber M, Grobbee DE, Schrover IM, et al. Comparison of a morning polypill, evening polypill and individual pills on LDL-cholesterol, ambulatory blood pressure and adherence in high-risk patients; a randomized crossover trial. Int J Cardiol. 2015;181:193–199. doi:10.1016/j.ijcard.2014.11.176

4. Csoma B, Bikov A. The role of the circadian rhythm in dyslipidemia and vascular inflammation leading to atherosclerosis. Int J Mol Sci. 2023;24(18):14145. doi:10.3390/ijms241814145

5. Park S, Ihm SH, Cho IJ, et al. Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertension. Clin Hypertens. 2023;29(1):25. doi:10.1186/s40885-023-00249-2

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.